Ikarian Capital, LLC Options Holdings

Ikarian Capital, LLC

  • $606 Million
  • Q4 2024

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
XBI
Spdr Ser Tr Spdr S&P Biotech E

ETFs
PUT
$67.5 Million
750K
Q4 2024
Added 50.0%
XBI
Spdr Ser Tr Spdr S&P Biotech E

ETFs
CALL
$63 Million
700K
Q4 2024
Added 50.0%
TSN
Tyson Foods, Inc.

Consumer Defensive
PUT
$36.2 Million
630K
Q4 2024
New holding
AMGN
Amgen Inc

Healthcare
CALL
$19.3 Million
74K
Q4 2024
Reduced 49.32%
BBIO
Bridge Bio Pharma, Inc.

Healthcare
CALL
$19.2 Million
700K
Q4 2024
New holding
PPC
Pilgrims Pride Corp

Consumer Defensive
PUT
$13.6 Million
300K
Q4 2024
New holding
RNA
Avidity Biosciences, Inc.

Healthcare
PUT
$11.6 Million
400K
Q4 2024
New holding
INSM
Insmed Inc

Healthcare
CALL
$10.4 Million
150K
Q4 2024
New holding
SRPT
Sarepta Therapeutics, Inc.

Healthcare
CALL
$9.85 Million
81K
Q4 2024
New holding
AXSM
Axsome Therapeutics, Inc.

Healthcare
CALL
$8.46 Million
100K
Q4 2024
New holding
CALM
Cal Maine Foods Inc

Consumer Defensive
PUT
$7.72 Million
75K
Q4 2024
New holding
DYN
Dyne Therapeutics, Inc.

Healthcare
PUT
$6.62 Million
281K
Q4 2024
Added 111.13%
BGNE
Bei Gene, Ltd.

Healthcare
CALL
$5.5 Million
29.8K
Q3 2024
New holding
AKRO
Akero Therapeutics, Inc.

Healthcare
PUT
$5.54 Million
199K
Q4 2024
Added 0.05%
VIR
Vir Biotechnology, Inc.

Healthcare
CALL
$5.29 Million
720K
Q4 2024
New holding
CLDX
Celldex Therapeutics, Inc.

Healthcare
PUT
$5.19 Million
206K
Q4 2024
Reduced 32.73%
CAPR
Capricor Therapeutics, Inc.

Healthcare
CALL
$5 Million
361K
Q4 2024
Added 20.37%
SRRK
Scholar Rock Holding Corp

Healthcare
CALL
$4.41 Million
102K
Q4 2024
Reduced 49.48%
MRNA
Moderna, Inc.

Healthcare
PUT
$4.16 Million
100K
Q4 2024
New holding
CAPR
Capricor Therapeutics, Inc.

Healthcare
PUT
$4.16 Million
300K
Q4 2024
Added 20.37%
CRVS
Corvus Pharmaceuticals, Inc.

Healthcare
CALL
$3.92 Million
754K
Q4 2024
New holding
VRDN
Viridian Therapeutics, Inc.\De

Healthcare
CALL
$3.36 Million
175K
Q4 2024
Reduced 12.45%
RNA
Avidity Biosciences, Inc.

Healthcare
CALL
$2.91 Million
100K
Q4 2024
New holding
CRVS
Corvus Pharmaceuticals, Inc.

Healthcare
PUT
$2.6 Million
500K
Q4 2024
New holding
NVAX
Novavax Inc

Healthcare
CALL
$2.41 Million
300K
Q4 2024
New holding
TEVA
Teva Pharmaceutical Industries LTD

Healthcare
CALL
$2.2 Million
100K
Q4 2024
New holding
RCUS
Arcus Biosciences, Inc.

Healthcare
CALL
$2.1 Million
141K
Q4 2024
Added 24.01%
HROW
Harrow Health, Inc.

Healthcare
CALL
$1.96 Million
58.3K
Q4 2024
New holding
BMEA
Biomea Fusion, Inc.

Healthcare
PUT
$1.67 Million
431K
Q4 2024
Added 713.4%
GALT
Galectin Therapeutics Inc

Healthcare
PUT
$1.43 Million
1.2M
Q4 2024
Added 140.0%
GALT
Galectin Therapeutics Inc

Healthcare
CALL
$1.43 Million
1.2M
Q4 2024
Added 140.0%
ALT
Altimmune, Inc.

Healthcare
CALL
$1.19 Million
166K
Q4 2024
New holding
ALT
Altimmune, Inc.

Healthcare
PUT
$1.19 Million
166K
Q4 2024
New holding
SANA
Sana Biotechnology, Inc.

Healthcare
CALL
$1.06 Million
650K
Q4 2024
Reduced 23.08%
SANA
Sana Biotechnology, Inc.

Healthcare
PUT
$815,000
500K
Q4 2024
Reduced 23.08%
IMUX
Immunic, Inc.

Healthcare
CALL
$635,000
636K
Q4 2024
New holding
ABEO
Abeona Therapeutics Inc.

Healthcare
CALL
$360,000
65K
Q4 2024
New holding
CADL
Candel Therapeutics, Inc.

Healthcare
PUT
$31,000
3.6K
Q4 2024
New holding
CADL
Candel Therapeutics, Inc.

Healthcare
CALL
$31,000
3.6K
Q4 2024
New holding
Anaptysbio Inc
PUT
$0
311K
Q4 2024
Reduced 23.13%
EWTX
Edgewise Therapeutics, Inc.

Healthcare
PUT
$5,000
200
Q4 2024
New holding
Soleno Therapeutics Inc
PUT
$0
75K
Q4 2024
New holding
Anaptysbio Inc
CALL
$0
250K
Q4 2024
Reduced 23.13%
Perspective Therapeutics Inc
PUT
$0
107K
Q4 2024
Added 39.04%
Neumora Therapeutics Inc.
CALL
$0
900K
Q4 2024
Reduced 12.5%
Neumora Therapeutics Inc.
PUT
$0
350K
Q4 2024
Reduced 12.5%
Ginkgo Bioworks Holdings Inc
CALL
$0
770K
Q4 2024
New holding
Solid Biosciences Inc
CALL
$0
300K
Q3 2024
New holding

Summary

  • Portfolio
  • No. of Stocks 171
  • Current Value $606 Million
  • Prior Value $573 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 44 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 56 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email